A cancer cell killed by chemotherapy doesn't necessarily stay dead, CU researchers have learned.
CU researchers are closing in on the cause of a common of ailment – the runny nose.
Bioscience 2 on the Fitzsimons Life Science District will house CU's bioengineering graduate program and startup medical companies.
Stroke risk is high following a shingles episode, but patients who take antiviral medication have a reduced risk.
CU researchers have found a segment of DNA that might be linked to the severity of autism.
Marijuana in pill or spray form reduces MS symptoms, and many patients are using it, despite the lack of thorough research.
A CU researcher says alligators' mysteriously good hearing is the result of air-filled channels connecting the middle ears - a trait similar to that of birds.
Pain following a joint replacement may be caused by an allergic reaction to materials used in the operation.
Anschutz researchers earned a $3 million grant to study causes and treatment of childhood strokes, which cause lifelong problems.
A new drug tested at University of Colorado Hospital can cure most patients with Hepatitis C within 12 weeks, researchers say.
Leukemia patients in clinical trials at Anschutz are taking advantage of life-saving drugs made available by new federal legislation.
A two-drug therapy that blocks separate melanoma growth pathways is helping patients at CU Cancer Center.
A study founded in 1993 with 30,000 participants is helping CU's Barbara Davis Center answer the question: Why do some people get Type 1 diabetes?
Women make up fewer than one-third of researchers and engineers nationally; a CU advocate says attempts to attract girls to these fields needs to start early.
Why does exercise help some but not all people lose weight? That's what CU researchers plan to find out.